Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

18.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 70.00
  • 52 Week Low: 12.00
  • Currency: UK Pounds
  • Shares Issued: 92.53m
  • Volume: 463,542
  • Market Cap: £17.12m
  • RiskGrade: 747

Geographical - by origin

  30-Jun-1130-Jun-1030-Jun-0930-Jun-08
Revenue
Asia0.132%0.02n/a0.01n/an/an/a
Europe1.4525%0.7814%0.7619%0.6331%
UK0.275%0.417%0.6917%0.5527%
USA3.9068%4.5379%2.5163%0.8843%
Total 5.75100% 5.74100% 3.97100% 2.07100% 
 
Profit Before Tax
Unanalysed0.36100%0.35100%(0.67)100%(1.33)100%
Total 0.36100% 0.35100% (0.67)100% (1.33)100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  30-Jun-1130-Jun-1030-Jun-0930-Jun-08
Revenue
Bio-markersn/an/an/an/a0.6717%0.157%
Contract Research Services3.0052%2.5244%2.3058%1.9193%
Novel Therapies1.6228%2.4242%1.0025%n/an/a
Personalised Medicine1.1320%0.8014%n/an/an/an/a
Total 5.75100% 5.74100% 3.97100% 2.07100% 
 
Profit Before Tax
Bio-markersn/an/an/an/a0.01n/a(0.06)n/a
Contract Research Services0.9757%0.72n/a0.56n/a0.46n/a
Novel Therapies0.6438%0.99n/a(0.16)n/a(0.91)n/a
Personalised Medicine0.095%(0.10)n/an/an/an/an/a
Unanalysed(1.34)n/a(1.26)n/a(1.08)n/a(0.82)n/a
Total 0.36100% 0.35n/a (0.67)n/a (1.33)n/a 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page